热点
"GLP-1激动剂" 相关文章
#279 - AMA #53: Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins
The Peter Attia Drive 2025-09-25T10:02:34.000000Z
#324 ‒ Metabolism, energy balance, and aging: How diet, calorie restriction, and macronutrients influence longevity and metabolic health | Eric Ravussin, Ph.D.
The Peter Attia Drive 2025-09-25T10:01:52.000000Z
30 Days of Retatrutide
少点错误 2025-09-04T16:56:47.000000Z
“减肥神药”能为社会省下万亿美元？
虎嗅 2025-04-11T07:14:47.000000Z
#320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape
The Peter Attia Drive 2024-10-07T08:11:35.000000Z
#246 - AMA #45:  Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent
The Peter Attia Drive 2024-07-23T16:53:16.000000Z
#279 - AMA #53: Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins
The Peter Attia Drive 2024-07-17T00:26:27.000000Z